How valuation works in a live deal

A range, not a number

A generalist technical interview tests whether you can build a discounted cash flow model, run a set of trading comparables, and explain the mechanical difference between trading comps and precedent transactions (a topic covered fully in M&A terms interviewers expect you to know, along with accretion and dilution, earn-outs, and goodwill, none of which this article re-explains). What an M&A-specific interview adds on top is judgment about how those tools actually get combined and used once a real negotiation is underway.

In a live deal, valuation output is not a single defensible number, it is a range, commonly visualized as a "football field," a horizontal bar chart stacking the value ranges implied by several methodologies side by side so a board or client can see where they overlap and where they diverge. The width and shape of that overlap is itself informative: methodologies that cluster tightly together give a client confidence in a price; methodologies that scatter widely signal genuine valuation uncertainty that a negotiation will need to resolve through structure (an earn-out, a collar on a stock deal) rather than through a single number both sides simply agree to.

The core methodologies and what each one answers

Each methodology has known blind spots that the others partially correct for, which is the entire reason a banker uses several rather than picking the "best" one. A DCF is only as good as its assumptions and is notoriously sensitive to the discount rate and terminal value, both of which involve real judgment calls rather than observable facts. Trading comps and precedent transactions are grounded in real market data but reflect whatever the market or a specific prior deal happened to price at a point in time, which may not reflect the target's specific circumstances. An LBO analysis answers a narrower question, what a financial buyer's return math supports, but is a genuinely useful floor, since a price a sponsor would not pay is a meaningful signal about where the market's downside sits, even for a client who is not selling to a sponsor at all.

Premiums paid analysis

For a public company sale specifically, premiums paid analysis is a distinct and heavily tested piece of the toolkit. It studies what percentage premium acquirers have historically paid over a target's unaffected share price, the price before the market had any indication a deal was coming, across a set of comparable prior transactions. This matters because a board evaluating a bid needs a benchmark for whether an offered premium is generous or thin relative to what similar sellers have received, and it is a genuinely different question from asking whether the absolute dollar price is fair.

The unaffected price itself is worth understanding precisely, because it is a common source of confusion in interviews. If rumors of a deal leak before an official announcement, a target's stock often runs up in anticipation, and benchmarking a subsequent offer against that already-elevated price makes the premium look artificially thin. Bankers typically identify a date before any leak or rumor, sometimes 20 or 30 trading days prior to announcement, as the true unaffected reference point, and present the premium relative to that date alongside the premium relative to the most recent undisturbed price, so the board sees both.

Contribution analysis: the tool unique to stock-for-stock deals

When an acquisition is structured partly or entirely in stock, a valuation question arises that does not exist in an all-cash deal: what ownership split in the combined company is fair to each side's shareholders. Contribution analysis addresses this directly, comparing what percentage of the combined company's revenue, EBITDA, net income, and sometimes other metrics each party contributes, and comparing those contribution percentages to the ownership split the deal actually proposes.

A target contributing, say, thirty percent of combined EBITDA but receiving only twenty percent of the combined company's shares has a real basis to push back, all else equal, though "all else equal" rarely holds; a party with faster growth, better margins, or a control premium being paid to its shareholders can justify receiving a smaller ownership share than its current contribution alone would suggest. Contribution analysis is best understood as a starting point for the negotiation over ownership split in a merger of equals or a large stock-for-stock deal, not a formula that mechanically determines the answer, and interviewers who ask about it are usually testing whether you understand that nuance rather than expecting you to just compute a ratio.

Synergies: sizing them and stress-testing them

Every strategic acquisition pitch includes a synergies case, projected cost savings or revenue benefits the combined company expects to realize that neither company could achieve alone, and every experienced banker treats a synergies number with real skepticism until it survives scrutiny. Cost synergies (eliminating duplicate corporate functions, combining supply chains, closing redundant facilities) are generally viewed as more credible and more likely to actually materialize than revenue synergies (cross-selling into the combined customer base, pricing power from reduced competition), because cost synergies are largely within management's direct control while revenue synergies depend on customer behavior nobody can fully predict.

A rigorous synergies analysis breaks the total estimate down by category, assigns a probability or a haircut to each category based on how confident management genuinely is, and phases the realization over time rather than assuming the full run-rate benefit shows up immediately. This matters enormously in a deal context because synergies feed directly into how much a buyer can justify paying: a buyer confident in a large, quickly realized cost synergy case can justify a higher price than one relying on speculative revenue synergies that may take years to show up, if they show up at all. The classic cautionary tale interviewers reference is the AOL Time Warner merger, where an ambitious synergy and strategic rationale case did not survive contact with reality, and the combination ultimately destroyed enormous value; it is worth knowing by name specifically because interviewers use it to test whether you treat "synergies" as a real, provable number or as a plug that makes a deal model produce the answer a client wants.

Turning a range into a negotiating position

None of this analysis matters in isolation from the actual negotiation it is meant to support. On the sell-side, a banker uses the top of a defensible range to set an opening ask and to justify pushing back on an early, lowball bid, while privately understanding where the range's lower bound sits as a walk-away point below which the board would rather stay independent than sell. On the buy-side, the same tools are used to establish the maximum price the client can pay and still credibly defend the deal to its own board or investment committee, and to avoid being anchored by a seller's framing of value that leans on the most favorable methodology in the football field rather than the full range.

Sensitivity analysis is the mechanical link between the valuation range and the actual negotiation: running the DCF and the synergies case across a spread of assumptions (a range of discount rates, a range of synergy realization probabilities, a range of exit multiples) shows a client not just what the base case implies, but how much the recommended price depends on assumptions that could reasonably go the other way. A well-prepared banker walks into a board meeting able to say not just "the range is X to Y" but "here is what would need to be true for the top of that range to be the right price, and here is how confident we are that it will be true," which is precisely the kind of judgment a well-built merger model is meant to support, covered further in what a merger model actually tests.

Practice question

Walk me through how you'd build a valuation range for a company in a live sale process, and how you'd actually use that range once bids start coming in.

I'd build the range from several methodologies rather than a single number: a discounted cash flow based on the company's own projected cash flows, trading comparables from similar public companies, precedent transactions showing what buyers have actually paid for comparable businesses, and a leveraged buyout analysis showing what a financial sponsor could pay and still hit a reasonable return, which acts as a useful floor. If it's a public company, I'd also run a premiums paid analysis benchmarked against the unaffected share price, since a board needs to know whether an offered premium is generous or thin relative to what similar sellers have received. I'd expect these methodologies to cluster in some areas and diverge in others, and where they diverge tells you where the real uncertainty is. Once bids start coming in, I'd use the top of that range to justify pushing back on an early, low bid, but I'd also privately know where the range's lower bound sits, since that's effectively the walk-away point below which the board might prefer to stay independent. If any bidder is proposing a mostly stock deal, I'd also want a contribution analysis to sanity-check the proposed ownership split against what each side is actually contributing to the combined company. Throughout, I'd stress-test any synergy assumptions embedded in a strategic buyer's price, since inflated synergy cases are one of the most common ways a headline price looks better than the deal actually is.

What the interviewer is listening for: Whether you understand valuation as a negotiating tool built from multiple methodologies rather than a single academic answer, and whether you can name the deal-specific tools, premiums paid, contribution analysis, synergy stress-testing, that a classroom DCF exercise never covers.